Mufaziya Mursheed, MD
Internal Medicine · Worcester, MANPI 1841861184
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 70 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 17 manufacturers, the largest accounting for just 20.7% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2022 at $565 and has fallen 71.0% since, to $164 in 2024.
Across 70 payments — averaging $18.83 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- E.r. Squibb & Sons, L.L.C.$273
- AstraZeneca$185
- Gilead$154
- AbbVie$133
- Bayer$90
- Boehringer Ingelheim$80
- plus $403 from 11 others
What the payments were for
- Food & beverage$1,318100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| E.r. Squibb & Sons, L.L.C. | 17 | $273 |
| AstraZeneca(2 entities) | 10 | $185 |
| Gilead | 7 | $154 |
| AbbVie | 6 | $133 |
| Bayer | 4 | $90 |
| Boehringer Ingelheim | 5 | $80 |
| Johnson & Johnson | 3 | $66 |
| Alcresta Therapeutics, Inc. | 3 | $60 |
| Pfizer | 4 | $54 |
| GSK | 3 | $43 |
| Karyopharm Therapeutics Inc. | 2 | $32 |
| Seagen Inc. | 1 | $30 |
| Otsuka America Pharmaceutical, Inc. | 1 | $29 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $27 |
| Alnylam Pharmaceuticals Inc. | 1 | $22 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 1 | $22 |
| Novartis | 1 | $18 |
How this compares
$1,318 in reported general payments places this provider in the 85th percentile of 4,983 internal medicine providers in Massachusetts.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other internal medicine in Worcester
- David SchenkeinBoston$5M
- Alan GarberCambridge$4.9M
- John FallonBoston$1.8M
- Michael MendelsohnBoston$1.6M
- Sandra RichmanBrookline$1.4M
- Gaurav SingalBoston$798K
- Asit ParikhBoston$486K
- Noopur RajeBoston$481K
- Daniel KuritzkesBoston$443K
- Xiuning leBoston$364K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.